Manitoba Daily

Friday, January 28, 2022

COVID-19 patients in Manitoba will be treated with monoclonal antibodies

Monoclonal antibodies will be given to some COVID-19 patients in Manitoba

Key takeaways:

  • Now, people in Manitoba who are unvaccinated or immunocompromised and have mild or moderate COVID-19 symptoms have a new treatment option.
  • Health Canada approved the treatment based on limited clinical testing and safety, efficacy, and quality reviews.

Unvaccinated and immunocompromised people in Manitoba with mild or moderate COVID-19 symptoms now have a new treatment option, thanks to the province’s announcement that monoclonal antibody treatment would be made available.

Unvaccinated, partially vaccinated, and immunocompromised people who meet certain criteria can receive the one-time intravenous treatment, which is only available by referral.

Also read: In the Tom Brady Super Bowl ring fraud case, a man will plead guilty

In a memo to healthcare providers dated Nov. 20, 2021, and posted on its website, Manitoba Shared Health identified three distinct groups of people who may be offered the treatment:

  • People aged 40 and up have never been infected with COVID-19 and have not been fully vaccinated.
  • People between the ages of 18 and 40 who have diabetes, smoking, obesity, heart disease, kidney disease, lung disease, or cancer and are unvaccinated or partially vaccinated.
  • Immunocompromised adults, such as those undergoing active treatment for solid tumors, organ transplant recipients, and those taking a variety of immunosuppressive drugs.
Monoclonal antibodies will be given to some COVID-19 patients in Manitoba.
Monoclonal antibodies will be given to some COVID-19 patients in Manitoba. Image from The Conversation

According to the province’s memo, unvaccinated patients should be encouraged to get the COVID-19 shot but should wait 90 days after receiving monoclonal antibody treatment.

According to the province’s website, Health Canada approved the treatment based on limited clinical testing and its safety, efficacy, and quality reviews.

Antibodies are produced in response to the treatment, which fights the virus that causes COVID-19. It may be given to people at risk of developing severe illness early in the disease.

Patients can receive treatment at several locations across the province after receiving a referral from a healthcare provider.

Source: CBC News

Get Canada and Manitoba’s top News, Market news, and other worldwide news only on Manitoba Daily.

Show More

Leave a Reply

Your email address will not be published. Required fields are marked *